145 related articles for article (PubMed ID: 38571691)
1. Turmeric Inhibits MDA-MB-231 Cancer Cell Proliferation, Altering miR-638-5p and Its Potential Targets.
Kaya M; Abuaisha A; Suer I; Emiroglu S; Abanoz F; Palanduz S; Cefle K; Ozturk S
Eur J Breast Health; 2024 Apr; 20(2):102-109. PubMed ID: 38571691
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
[TBL] [Abstract][Full Text] [Related]
3. Induced expression of miR-1250-5p exerts tumor suppressive role in triple-negative breast cancer cells.
Shuaib M; Kumar S
J Cell Biochem; 2023 Feb; 124(2):282-293. PubMed ID: 36548440
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
[TBL] [Abstract][Full Text] [Related]
6. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
Shuaib M; Chaudhri S; Kumar S
Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
[TBL] [Abstract][Full Text] [Related]
7. Differences of time-dependent microRNA expressions in breast cancer cells.
Bozkurt SB; Ozturk B; Kocak N; Unlu A
Noncoding RNA Res; 2021 Mar; 6(1):15-22. PubMed ID: 33385103
[TBL] [Abstract][Full Text] [Related]
8. Natural Steroidal Lactone Induces G1/S Phase Cell Cycle Arrest and Intrinsic Apoptotic Pathway by Up-Regulating Tumor Suppressive miRNA in Triple-Negative Breast Cancer Cells.
Shuaib M; Prajapati KS; Gupta S; Kumar S
Metabolites; 2022 Dec; 13(1):. PubMed ID: 36676955
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis.
Xu W; Song C; Wang X; Li Y; Bai X; Liang X; Wu J; Liu J
Aging (Albany NY); 2021 Jan; 13(1):228-240. PubMed ID: 33472170
[TBL] [Abstract][Full Text] [Related]
10. The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cells.
Li D; Wang H; Song H; Xu H; Zhao B; Wu C; Hu J; Wu T; Xie D; Zhao J; Shen Q; Fang L
Oncotarget; 2017 Oct; 8(49):85276-85289. PubMed ID: 29156719
[TBL] [Abstract][Full Text] [Related]
11. Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway.
Bao C; Liu T; Qian L; Xiao C; Zhou X; Ai H; Wang J; Fan W; Pan J
J Cancer; 2021; 12(1):76-88. PubMed ID: 33391404
[No Abstract] [Full Text] [Related]
12. Ectopic expression of tumor suppressive miR-181c-5p downregulates oncogenic Notch signaling in MDA-MB-231 cells.
Shuaib M; Kumar S
Pathol Res Pract; 2024 Jan; 253():155017. PubMed ID: 38101160
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.
Lv Y; Lv X; Yang H; Qi X; Wang X; Li C; Shang X; Guo H; Zhang J; Zhang Y
Front Oncol; 2021; 11():678474. PubMed ID: 34026654
[TBL] [Abstract][Full Text] [Related]
14. MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2.
Wang LB; Feng L; He J; Liu B; Sun JG
Math Biosci Eng; 2019 Jul; 16(6):6923-6933. PubMed ID: 31698596
[No Abstract] [Full Text] [Related]
15. miR-744/eNOS/NO axis: A novel target to halt triple negative breast cancer progression.
El Kilany FH; Youness RA; Assal RA; Gad MZ
Breast Dis; 2021; 40(3):161-169. PubMed ID: 33749631
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling.
Chen J; Chen Z; Huang J; Chen F; Ye W; Ding G; Wang X
Oncol Lett; 2018 Mar; 15(3):3017-3023. PubMed ID: 29435032
[TBL] [Abstract][Full Text] [Related]
17. The role of microRNA-4723-5p regulated by c-myc in triple-negative breast cancer.
Jin XX; Gao C; Wei WX; Jiao C; Li L; Ma BL; Dong C
Bioengineered; 2022 Apr; 13(4):9097-9105. PubMed ID: 35382692
[TBL] [Abstract][Full Text] [Related]
18. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1.
Selem NA; Nafae H; Manie T; Youness RA; Gad MZ
Pathol Res Pract; 2023 Aug; 248():154579. PubMed ID: 37301086
[TBL] [Abstract][Full Text] [Related]
19. MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest.
Wang Y; Wu N; Zhang J; Wang H; Men X
Onco Targets Ther; 2020; 13():4089-4097. PubMed ID: 32494162
[TBL] [Abstract][Full Text] [Related]
20. MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.
Wu ZS; Wu Q; Wang CQ; Wang XN; Wang Y; Zhao JJ; Mao SS; Zhang GH; Zhang N; Xu XC
BMC Cancer; 2010 Oct; 10():542. PubMed ID: 20932331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]